BlueCross BlueShield of Tennessee Medical Policy Manual

Genitourinary System

• Biofeedback and Neurofeedback

• Bulking Agents for the Treatment of Vesicoureteral Reflux (VUR) and Incontinence

• Cryosurgical Ablation of Solid Tumors

• Gene Expression Profile Analysis for Prostate Cancer Management

• Hemodialysis in the Home

• Lutetium Lu 177 Vipivotide Tetraxetan (Pluvicto®)

• MRI-Guided Focal Laser Ablation for Prostate Cancer

• Nerve Graft with Radical Prostatectomy

• Pancreas/Pancreas-Kidney/Pancreatic Islet Cell Transplantation

• Pelvic Floor Stimulation

• P ercutaneous Arteriovenous Fistula (pAVF)

• Prostate Specific Antigen (PSA)

• Radiotherapy for Prostate Cancer

• S aturation Biopsy for Diagnosis and Staging of Prostate Cancer

• T ransvaginal and Transurethral Radiofrequency Tissue Remodeling for Urinary Stress Incontinence

This document has been classified as public information.